CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

AstraZeneca Collaborating With CSPC Pharma in siRNA Drug Deal Worth Up to $1.77 Billion

PartnershipPositive
AI Analysis

Summary

AstraZeneca entered into a collaboration with CSPC Pharma for a siRNA drug deal with potential value up to $1.77 billion. The deal involves a partnership focused on siRNA-based therapeutics development.

Importance:7/10
Sentiment:
0.60
partnershiplicensing dealsiRNAcollaboration
Related Companies

Read the original article

Published by yahoo_finance on July 2, 2026 11:43 AM

Read Original